Development of a New Cytomegalovirus (CMV) Immunoglobulin M (IgM) Immunoblot for Detection of CMV-Specific IgM

Journal of Clinical Microbiology - Tập 36 Số 11 - Trang 3337-3341 - 1998
Tiziana Lazzarotto1, Alessandro Ripalti1, Giovanna Bergamini1, M. C. Battista1, P. Spezzacatena1, Fabio Campanini1, P. Pradelli1, Stefania Varani1, Liliana Gabrielli1, G T Maine2, Maria Paola Landini1
1Department of Clinical and Experimental Medicine, Section of Microbiology, University of Bologna, Bologna, Italy,1 and
2Abbott Laboratories, Abbott Park, Illinois2

Tóm tắt

ABSTRACT We developed a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot to detect CMV-specific IgM in human sera. The new test contains four viral proteins (vp150, vp82, vp65, and vp28) purified from viral particles and four recombinant proteins (rp150, rp130, rp52, and rp38) purified from Escherichia coli . These antigens were individually loaded onto nitrocellulose strips, and the strips were then used to detect CMV-specific IgM by using a μ-specific conjugate. The new assay was evaluated in parallel with one or two IgM enzyme-linked immunosorbent assays (ELISAs) to test 592 serum samples from different groups of latently or acutely infected individuals. The sensitivity of the new assay with respect to the consensus of two ELISAs was 100%, the specificity was 98.6%, the positive predictive value was 96.9%, and the negative predictive value was 100%. We also evaluated the new test by testing sera from pregnant women and transplant recipients with a known clinical history. Our results suggest that the new test combines high sensitivity with high specificity, characteristics that are mutually exclusive with the other commercially available tests. Furthermore, a statistically significant correlation was observed between the number of IgM-reactive bands and the elevated risk of transmission from CMV-infected pregnant women to their offspring.

Từ khóa


Tài liệu tham khảo

10.1093/nar/25.17.3389

10.1007/BF01310938

10.1093/infdis/171.5.1115

10.1016/0166-0934(93)90090-E

Chee M. S. Bankier A. T. Beck S. Bohni R. Brown C. M. Cerny T. Horsnell T. Hutchinson C. A. Kouzarides T. Martinetti J. A. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169.Curr. Top. Microbiol. Immunol.1541990125169

10.1136/jcp.42.10.1070

10.1093/infdis/157.2.319

Griner P. F. Mayewski R. J. Mushlin A. I. Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications.Ann. Intern. Med.941981557592

Kraat Y. J. Stals F. S. Landini M. P. Bruggeman C. A. Cytomegalovirus IgM antibody detection: comparison of five assays.New Microbiol.161993297307

10.1002/(SICI)1096-9071(199603)48:3<289::AID-JMV13>3.0.CO;2-8

10.1007/BF01318089

10.1016/0166-0934(88)90113-9

10.1128/jcm.28.6.1375-1379.1990

10.1002/rmv.1980020203

10.1128/jcm.33.10.2535-2542.1995

10.1002/jcla.1860060409

10.1007/BF01309762

10.1128/cdli.3.5.597-600.1996

10.1128/jcm.35.2.393-397.1997

10.1128/cdli.4.4.483-486.1997

10.1128/cdli.4.4.469-473.1997

10.1128/cdli.3.3.358-360.1996

10.1093/infdis/161.3.454

10.1002/jcla.1860030607

10.1002/jmv.1890220109

10.1128/jcm.26.4.654-661.1988

10.1093/infdis/160.1.159

Ripalti A. Boccuni M. C. Campanini F. Bergamini G. Lazzarotto T. Battista M. C. Dalla Casa B. Landini M. P. Construction of a polyepitope fusion antigen of human cytomegalovirus ppUL32 and detection of specific antibodies by ELISA.Microbiologica181994112

10.1016/0166-0934(94)90015-9

10.1128/jcm.31.3.629-635.1993

10.1099/0022-1317-75-12-3287

10.1542/peds.65.2.251

10.1128/jcm.21.6.930-935.1985

10.1002/jmv.1890250208

10.1128/jcm.13.3.416-422.1981

10.1128/jcm.32.4.981-986.1994

10.1128/jcm.33.7.1927-1930.1995